MRNA

Moderna in final talks to build an mRNA manufacturing and R&D hub in the UK — report
Endpoints
Mon, 02/14/22 - 10:57 am
Moderna Theraeputics
Europe
R&D
drug manufacturing
MRNA
Daiichi makes play for share of Japan’s COVID booster market
Pharmaforum
Mon, 01/31/22 - 10:49 am
Daiichi Sankyo
COVID-19
vaccines
MRNA
Japan
DS-5670
JPM22: Pfizer's big bet on mRNA, Biogen 'proven wrong' on Aduhelm price and the next cell therapies
BioPharma Dive
Mon, 01/10/22 - 11:52 pm
JPMHC 2022
Pfizer
MRNA
Biogen
Aduhelm
cell therapy
Pfizer expands into gene editing with Beam research deal
BioPharma Dive
Mon, 01/10/22 - 11:30 am
Pfizer
Beam Therapeutics
MRNA
gene editing
Merck KGaA buys manufacturer of key component in mRNA medicines
BioPharma Dive
Thu, 01/6/22 - 12:37 pm
Merck
KGaA
MRNA
M&A
Exelead
Pfizer, BioNTech to develop shingles shot, after COVID-19 vaccine success
Reuters
Wed, 01/5/22 - 10:47 am
Pfizer
BioNTech
vaccines
MRNA
shingles
mRNA Epstein-Barr Virus Vaccine Candidate Launches Phase 1 Study
Precision Vaccines
Wed, 01/5/22 - 10:20 am
Moderna Therapeutics
vaccines
EBV
MRNA
clinical trials
mRNA-1189
Citing blood clot risks, CDC advisers recommend mRNA pandemic vaccines over J&J shot
Fierce Pharma
Fri, 12/17/21 - 12:02 am
JNJ
vaccines
COVID-19
blood clots
FDA
MRNA
Moderna plots mRNA vaccine factory in Australia that can churn out 100M doses per year
Endpoints
Tue, 12/14/21 - 11:01 am
Moderna Therapeutics
vaccines
drug manufacturing
MRNA
Australia
2021: the year mRNA therapeutics came of age
Pharmaforum
Mon, 12/13/21 - 10:55 am
MRNA
vaccines
COVID-19
Sanofi
AstraZeneca
Moderna Therapeutics
Pfizer
BioNTech
Moderna's flu data offer a clear lesson: mRNA isn't magic
Endpoints
Sat, 12/11/21 - 09:24 pm
Moderna Therapeutics
MRNA
vaccines
flu vaccines
Moderna, hoping to prove it's no one-trick COVID pony, posts early peek at mRNA flu shot hopeful
Fierce Biotech
Fri, 12/10/21 - 10:57 am
Moderna Therapeutics
MRNA
clinical trials
vaccines
mRNA-1010
flu vaccines
Could Moderna and AstraZeneca's mRNA Heart Failure Drug Candidate Be a Winner?
Motley Fool
Sun, 12/5/21 - 10:47 pm
Moderna Therapeutics
AstraZeneca
AZD-8601
heart failure
MRNA
Sanofi aims to double vaccine sales by 2030, citing RSV and flu market expansion as key drivers
Fierce Pharma
Wed, 12/1/21 - 11:46 pm
Sanofi
vaccines
RSV
Flu
MRNA
pneumococcal disease
Like the flu vaccine every year, the FDA could move quickly on a variant-targeted Covid vaccine
Endpoints
Mon, 11/29/21 - 11:11 am
FDA
vaccines
COVID-19
Omicron COVID-19 variant
MRNA
Pfizer
Moderna Therapeutics
White House preps to pump billions into mRNA vaccine manufacturing capacity — but Moderna and Pfizer will have to buy in
Endpoints
Thu, 11/18/21 - 10:55 pm
White House
vaccines
drug manufacturing
MRNA
COVID-19
CureVac Publishes in Nature Preclinical Data of Second-Generation COVID-19 Candidate, CV2CoV, Demonstrating Comparable Antibody Levels to Licensed mRNA Vaccine
Yahoo Finance
Thu, 11/18/21 - 10:36 am
CureVac
MRNA
vaccines
COVID-19
Where Will Moderna Be in 10 Years?
Motley Fool
Tue, 11/16/21 - 10:36 am
Moderna Therapeutics
COVID-19
vaccines
MRNA
Moderna, AstraZeneca announce positive AZD8601 data from Phase 2 study in heart failure
Seeking Alpha
Mon, 11/15/21 - 12:27 pm
Moderna Therapeutics
MRNA
AstraZeneca
clinical trials
heart failure
Moderna scraps lead mRNA chikungunya candidate after phase 1, slowing push beyond prophylactic vaccines
Fierce Biotech
Fri, 11/5/21 - 09:44 am
Moderna Therapeutics
vaccines
MRNA
chikungunya virus
clinical trials

Pages